Semaglutide, known by brand names such as Ozempic, Rybelsus, and Wegovy, is a medication prescribed to diabetics to assist with glycemic control when used in conjunction with diet and exercise. As a member of the GLP-1 receptor agonist class, Semaglutide works by slowing gastric motility, resulting in a longer feeling of fullness and decreased appetite and food intake. This medication is administered through a subcutaneous injection once a week.
